VAERS Explorer
Back to explore

Report #2840501

Received May 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
45 yrs
State
AZ
Recovered
Recovered
Vaccinated
Apr 2, 2025
Onset
Apr 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
SMALLMNKSMALLPOX + MONKEYPOX (JYNNEOS)BAVARIAN NORDIC296868IM / LA

Symptoms (1)

No adverse event

Symptom narrative

The treatment was the second dose of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.

Current illness

None reported

Medical history

HIV infection, asymptomatic Screen for STD (sexually transmitted disease) Screening for tuberculosis Amphetamine abuse, continuous (HCC) Anxiety Mood disorder Herpes simplex, episodic Chronic idiopathic urticaria S/P nasal septoplasty Allergic rhinitis Allergic conjunctivitis Shoulder impingement Chest wall pain Tobacco user Screening for anal cancer - overdue Need for measles-mumps-rubella (MMR) vaccine Other social stressors Compression fracture of L1 vertebra with routine healing Homelessness Chronic dermatitis of the feet History of syphilis Syphilis Vitamin D deficiency

Other medications

calcium carbonate-vitamin D3 (OS-CAL 500 + D3) 500 mg-5 mcg (200 unit) per tablet alendronate (FOSAMAX) 35 mg tablet cyclobenzaprine (FLEXERIL) 5 mg tablet abacavir-dolutegravir-lamivud (TRIUMEQ) 600-50-300 mg tablet loratadine (CLARITIN) 1

Allergies

NKDA

Lab data

N/A